mrjСовременная ревматологияModern Rheumatology Journal1996-70122310-158XIMA-PRESS, LLC10.14412/1996-7012-2010-642mrj-327Research ArticleСтатьиArticlesАртропатия Шарко: место встречи ревматолога и эндокринологаArtropatiya Sharko: mesto vstrechi revmatologa i endokrinologaКудаеваФ. М.KudaevaF M-EliseevM SEliseevM S-ВладимировС. А.VladimirovS A-БарсковаВ. Г.BarskovaV G-20101412201044№4 (2010)7782Copyright © Кудаева Ф.М., Eliseev M.S., Владимиров С.А., Барскова В.Г., 20102010Кудаева Ф.М., Eliseev M.S., Владимиров С.А., Барскова В.Г.Kudaeva F.M., Eliseev M.S., Vladimirov S.A., Barskova V.G.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://mrj.ima-press.net/mrj/article/view/327References<div><p>Sanders L.J., Frykberg R.G. Diabetic neuropathic osteoarthropathy: Charcot foot. In: The high risk foot in Diabetes Mellitus. Ed. by Frykberg R.G. New York: Churchill Livingstone, 1991.</p><p>Levin M.E., O'Neal L.W., Bowker J.H. Eds New York: Churchill Livingstone, 1991:297-338.</p><p>Sanders L.J., Frykberg R.G. Charcot foot. In: Levin M.E., O'Neal L.W., Bowker J.H. eds. The Diabetic Foot. St. Louis: Mosby, 1993:149-80.</p><p>Rajbhandari S.M., Jenkins R.C., Davies C. et al. Charcot neuroarthropathy in diabetes mellitus. Diabetologia 2002;45:1085-96.</p><p>Armstrong D.G., Todd W.F., Lavery L.A. et al. The natural history of acute Charcot's arthropathy in a diabetic foot specialty clinic. Diabetic Med 1997;14:357-63.</p><p>Brower A.C., Allman R.M. Pathogenesis of the neurotrophic joint: neurotraumatic vs. neurovascular. Radiology 1981;139:349-54.</p><p>Lavery L.A., Armstrong D.G., Walker S.C. Healing rates of diabetic foot ulcers associated with midfoot fracture due to Charcot's arthropathy. Diabetic Med 1997;14:46-9.</p><p>Fabrin J., Larsen K., Holstein P.E. Longterm follow-up in diabetic Charcot feet with spontaneous onset. Diabetes Care 2000;23:796-800.</p><p>Armstrong D.G., Lavery L.A. Elevated peak plantar pressures in patients who have Charcot arthropathy. J Bone Joint Surg Am 1998;80A:365-9.</p><p>Young M.J., Marshall A., Adams J.E. et al. neurological dysfunction, and the development of Charcot neuroarthropathy. Diabetes Care 1995;18:34-8.</p><p>Chantelau E., Onvlee G.J. Charcot Foot in Diabetes. Horm Metab Res 2006;38:361-367.</p><p>Yu G.V., Hudson J.R. Evaluation and treatment of stage 0 Charcot's neuroarthropathy of the foot and ankle. J Am Podiatr Med Assoc 2002;92:210-20.</p><p>Jeffcoate W. Vascular calcification and osteolysis in diabetic neuropathy - is RANK-L the missing link? Diabetologia 2004;47:1488-92.</p><p>Hofbauer L.C., Schoppet M. Clinical implications of the osteoprotegerin RANKL/RANK for bone and vascular diseases. JAMA 2004;292:490-5.</p><p>Mabilleau G., Petrova N.L., Edmonds M.E. et al. Increased osteoclastic activity in acute Charcot's osteoarthopathy: the role of receptor activator of nuclear factor-kappaB ligand. Diabetologia 2008;51:1035-40.</p><p>Sommer T.C., Lee T.H. Charcot Foot: The Diagnostic Dilemma. Am Fam Physician 2001;64:1591-8.</p><p>Eichenholtz S.N. Charcot joints. Springfield:Thomas, 1966.</p><p>Sella E.J., Barrette C. Staging of Charcot neuroarthropathy along the medial column of the foot in the diabetic patient. J Foot Ankle Surg 1999;38:34-40.</p><p>Kirsch T. Determinants of pathological mineralization. Current Opinion in Rheumatol 2006;18:174-80.</p><p>Zaka R., Williams C.J. Role of progressive ankylosis gene in cartilage mineralization. Current Opinion in Rheumatol 2006;18:181-6.</p><p>Graff R.D., Picher M., Lee G.M. Extracellular nucleotides, cartilage stress, and calcium crystal formation. Current Opinion in Rheumatol 2003;15:315-20.</p><p>Announ N., Guerne P.A. Calcium pyrophosphate dihydrate crystal induced arthropathy. Rev Med Suisse 2007 Mar 21;3(103):740-6.</p><p>Brodsky J.W. Outpatient diagnosis and care of the diabetic foot. Instr Course Lect 1993;42:121-39.</p><p>Brodsky J.W. The diabetic foot. In: Mann R.A., Coughlin M.J., eds. Surgery of the foot and ankle. 6th ed. St. Louis: Mosby, 1993.</p><p>Jude E.B., Boulton A.J. Medical treatment of Charcot's arthropathy. J Am Podiatr Med Assoc 2002;92:381-3.</p><p>Pitocco D., Ruotolo V., Caputo S. et al. Six-month treatment with alendronate in acute Charcot neuroarthropathy. Diabetes Care 2005;28(5):1214-5.</p><p>Bem R., Jircovsca A., Fejfarova V. et al. Intranasal calcitonin in the treatment of acute Charcot neuroosteoarthropathy. Diabetes Care 2006;29(6):1392-4.</p></div><br /><div><p>Sanders L.J., Frykberg R.G. Diabetic neuropathic osteoarthropathy: Charcot foot. In: The high risk foot in Diabetes Mellitus. Ed. by Frykberg R.G. New York: Churchill Livingstone, 1991.</p><p>Levin M.E., O'Neal L.W., Bowker J.H. Eds New York: Churchill Livingstone, 1991:297-338.</p><p>Sanders L.J., Frykberg R.G. Charcot foot. In: Levin M.E., O'Neal L.W., Bowker J.H. eds. The Diabetic Foot. St. Louis: Mosby, 1993:149-80.</p><p>Rajbhandari S.M., Jenkins R.C., Davies C. et al. Charcot neuroarthropathy in diabetes mellitus. Diabetologia 2002;45:1085-96.</p><p>Armstrong D.G., Todd W.F., Lavery L.A. et al. The natural history of acute Charcot's arthropathy in a diabetic foot specialty clinic. Diabetic Med 1997;14:357-63.</p><p>Brower A.C., Allman R.M. Pathogenesis of the neurotrophic joint: neurotraumatic vs. neurovascular. Radiology 1981;139:349-54.</p><p>Lavery L.A., Armstrong D.G., Walker S.C. Healing rates of diabetic foot ulcers associated with midfoot fracture due to Charcot's arthropathy. Diabetic Med 1997;14:46-9.</p><p>Fabrin J., Larsen K., Holstein P.E. Longterm follow-up in diabetic Charcot feet with spontaneous onset. Diabetes Care 2000;23:796-800.</p><p>Armstrong D.G., Lavery L.A. Elevated peak plantar pressures in patients who have Charcot arthropathy. J Bone Joint Surg Am 1998;80A:365-9.</p><p>Young M.J., Marshall A., Adams J.E. et al. neurological dysfunction, and the development of Charcot neuroarthropathy. Diabetes Care 1995;18:34-8.</p><p>Chantelau E., Onvlee G.J. Charcot Foot in Diabetes. Horm Metab Res 2006;38:361-367.</p><p>Yu G.V., Hudson J.R. Evaluation and treatment of stage 0 Charcot's neuroarthropathy of the foot and ankle. J Am Podiatr Med Assoc 2002;92:210-20.</p><p>Jeffcoate W. Vascular calcification and osteolysis in diabetic neuropathy - is RANK-L the missing link? Diabetologia 2004;47:1488-92.</p><p>Hofbauer L.C., Schoppet M. Clinical implications of the osteoprotegerin RANKL/RANK for bone and vascular diseases. JAMA 2004;292:490-5.</p><p>Mabilleau G., Petrova N.L., Edmonds M.E. et al. Increased osteoclastic activity in acute Charcot's osteoarthopathy: the role of receptor activator of nuclear factor-kappaB ligand. Diabetologia 2008;51:1035-40.</p><p>Sommer T.C., Lee T.H. Charcot Foot: The Diagnostic Dilemma. Am Fam Physician 2001;64:1591-8.</p><p>Eichenholtz S.N. Charcot joints. Springfield:Thomas, 1966.</p><p>Sella E.J., Barrette C. Staging of Charcot neuroarthropathy along the medial column of the foot in the diabetic patient. J Foot Ankle Surg 1999;38:34-40.</p><p>Kirsch T. Determinants of pathological mineralization. Current Opinion in Rheumatol 2006;18:174-80.</p><p>Zaka R., Williams C.J. Role of progressive ankylosis gene in cartilage mineralization. Current Opinion in Rheumatol 2006;18:181-6.</p><p>Graff R.D., Picher M., Lee G.M. Extracellular nucleotides, cartilage stress, and calcium crystal formation. Current Opinion in Rheumatol 2003;15:315-20.</p><p>Announ N., Guerne P.A. Calcium pyrophosphate dihydrate crystal induced arthropathy. Rev Med Suisse 2007 Mar 21;3(103):740-6.</p><p>Brodsky J.W. Outpatient diagnosis and care of the diabetic foot. Instr Course Lect 1993;42:121-39.</p><p>Brodsky J.W. The diabetic foot. In: Mann R.A., Coughlin M.J., eds. Surgery of the foot and ankle. 6th ed. St. Louis: Mosby, 1993.</p><p>Jude E.B., Boulton A.J. Medical treatment of Charcot's arthropathy. J Am Podiatr Med Assoc 2002;92:381-3.</p><p>Pitocco D., Ruotolo V., Caputo S. et al. Six-month treatment with alendronate in acute Charcot neuroarthropathy. Diabetes Care 2005;28(5):1214-5.</p><p>Bem R., Jircovsca A., Fejfarova V. et al. Intranasal calcitonin in the treatment of acute Charcot neuroosteoarthropathy. Diabetes Care 2006;29(6):1392-4.</p></div><br />
The authors declare that there are no conflicts of interest present.